Motivations for participating in a clinical trial on an avian influenza vaccine

Trials

M-Amparo Muñoz¹  Sarah Lafuente¹  Beatriz Serrano²  José M Bayas¹  Laura Costas² 

[1] Adult Vaccination Centre, Preventive Medicine and Epidemiology Service, Hospital Clinic-IDIBAPS, Barcelona, Spain;Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Barcelona, Spain

关键词: Avian influenza;    Vaccines;    Clinical trial;    Motivations;   

Others  :  1095661
DOI  :  10.1186/1745-6215-13-28

 received in 2011-09-16, accepted in 2012-03-27,  发布年份 2012

【 摘 要 】

In this study we describe the sociodemographic characteristics of people participating in a clinical trial on the safety and immunogenicity of a H5N1 influenza vaccine and we identify the main motivations for joining it.

【 授权许可】

   
2012 Costas et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Campbell CN, Mytton OT, McLean EM, Rutter PD, Pebody RG, Sachedina N, White PJ, Hawkins C, Evans B, Waight PA, Ellis J, Bermingham A, Donaldson LJ, Catchpole M: Hospitalization in two waves of pandemic influenza A(H1N1) in England. Epidemiol Infect 2010, 139:1560-1569.
• [2]Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY, Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5: Avian influenza A (H5N1) infection in humans. N Engl J Med 2005, 353:1374-1385. Erratum in: N Engl J Med 2006, 354:884
• [3]Soborg C, Mølbak K, Doherty TM, Ulleryd P, Brooks T, Coenen C, van der Zeijst B: Vaccines in a hurry. Vaccine 2009, 27:3295-3298.
• [4]Rumke HC, Bayas JM, de Juanes JR, Caso C, Richardus JH, Campins M, Rombo L, Duval X, Romanenko V, Schwarz TF, Fassakhov R, Abad-Santos F, von Sonnenburg F, Dramé M, Sänger R, Ballou WR: Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial. Vaccine 2008, 26:2378-2388.
• [5]Cheung AM, Lee Y, Kapral M, Scher J, Ho I, Lui-Yee D, Stewart DE: Barriers and motivations for women to participate in cardiovascular trials. J Obstet Gynaecol Can 2008, 30:332-337.
• [6]Colfax G, Buchbinder S, Vamshidar G, Celum C, McKirnan D, Neidig J, Koblin B, Gurwith M, Bartholow B: Motivations for participating in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2005, 39:359-364.
• [7]Halpern SD, Karlawish JH, Casarett D, Berlin JA, Townsend RR, Asch DA: Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency. Am Heart J 2003, 146:985-992.
• [8]Almeida L, Azevedo B, Nunes T, Vaz-da-Silva M, Soares-da-Silva P: Why healthy subjects volunteer for phase I studies and how they perceive their participation? Eur J Clin Pharmacol 2007, 63:1085-1094.
• [9]Nurgat ZA, Craig W, Campbell NC, Bissett JD, Cassidy J, Nicolson MC: Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer 2005, 92:1001-1005.
• [10]Stunkel L, Grady C: More than the money: a review of the literature examining healthy volunteer motivations. Contemp Clin Trials 2011, 32:342-352.